Location History:
- Budaors, HU (2008)
- Budaörs, HU (2010)
Company Filing History:
Years Active: 2008-2010
Title: Innovations in Pharmaceutical Chemistry: The Patents of Gabor Tarkanyi
Introduction
Gabor Tarkanyi, an accomplished inventor based in Budaörs, Hungary, has made significant contributions to the field of pharmaceutical chemistry. With a total of two patents to his name, Tarkanyi focuses on processes that enhance the preparation of complex chemical compounds used in various medical applications.
Latest Patents
Tarkanyi's latest patents exemplify his expertise in the synthesis of chirally pure compounds vital for therapeutic use. The first patent details a novel process for the preparation of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine, commonly known as nateglinide, in its crystalline form 'G'. This invention includes a method for creating chirally pure nateglinide by treating a lower alkyl ester with a base, forming an alkali salt, and subsequently liberating the product through acid addition. Additionally, this patent describes the preparation of nateglinide in crystalline form 'H' from other modifications.
The second patent introduces a new process for synthesizing high purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine. In this innovation, 2,3-dichlorobenzoyl cyanide is reacted with aminoguanidine salt in methanesulfonic acid to create an adduct, which is transformed into the desired product using magnesium oxide. The crude product resulting from this synthesis can be recrystallized from organic solvents to achieve high purity.
Career Highlights
Gabor Tarkanyi's association with Richter Gedeon Vegyeszeti Gyar Rt. marks a significant phase in his career, where he has collaborated with industry experts to pioneer pharmaceutical innovations. His work focuses on enhancing the efficacy and safety of therapeutic compounds, thus contributing to advancements in medical treatments.
Collaborations
Throughout his career, Tarkanyi has worked alongside notable colleagues such as Tibor Gizur and Jozsef Törley. Together, they aim to push the boundaries of pharmaceutical research, developing processes that could lead to improved medicinal applications and better patient outcomes.
Conclusion
In conclusion, Gabor Tarkanyi stands out as a dedicated inventor whose contributions to pharmaceutical chemistry have the potential to impact healthcare significantly. His two patents not only showcase his innovative spirit but also underline the importance of collaboration in advancing scientific research. As he continues his work at Richter Gedeon, Tarkanyi's future innovations are anticipated to further enhance the field of pharmaceuticals.